Drug recall · August 15, 2012
Copaxone recall
Why: Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30
- Lots / codes
Lot number X05011, Exp 08/13
- Quantity
- 6,647 cartons
- Company
- Teva Pharmaceuticals USA, Inc., Sellersville, PA
- Distribution
- Nationwide
- Initiated
- May 18, 2012 · Voluntary: Firm initiated
- Classified
- August 3, 2012
- Reported
- August 15, 2012
- Ended
- April 11, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Copaxone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.